US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

5  6  7  8    10    12  13  14  
Deals in Oncology Personalized Medicine Industry – Worldwide Analysis
5/27/2014 | published by: Renub Research
... by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals have been covered under different chapters in below mentioned topics. Collaboration Deals (Chapter No. 2.1) ...  |  read more...
USD 900
Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
XOMA Corporation (XOMA) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Therametrics holding AG (TMX) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Sangamo BioSciences, Inc. (SGMO) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Chronic Lymphocytic Leukaemia: KOL Insight
5/27/2014 | published by: FirstWord
... radically altering the treatment algorithm. From Roche’s improved anti-CD20 monoclonal antibody Gazyva, to Pharmacyclics/Janssen Biotech’s Imbruvica, the treatment landscape is being transformed. Drivers of change Targeted therapies. Most significantly, KOLs predict that therapies from Roche, ...  |  read more...
USD 4,995
Spherix Incorporated (SPEX) - Financial and Strategic SWOT Analysis Review
5/27/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Cosmetic Chemicals Markets in China
5/22/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
ROG – Penzberg Biologic Manufacturing Facility – Bavaria - Construction Project Profile
5/22/2014 | published by: World Market Intelligence
... including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. World "ROG – Penzberg Biologic Manufacturing ...  |  read more...
USD 75
Biotechnology Markets in China
5/22/2014 | published by: Asia Market Information & Development Company
... examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are ...  |  read more...
USD 4,000
Food Industry Market Research: Plunkett's Food Industry Almanac 2014: Food Industry Market Research, Statistics, Trends & Leading Companies
5/21/2014 | published by: Plunkett Research, Ltd.
... names top trends changing the industry for the mid term. Key Features: Industry trends analysis, market data and competitive intelligence Market forecasts and Industry Statistics Industry Associations and Professional Societies List In-Depth Profiles of hundreds ...  |  read more...
USD 349
Genmab A/S - Product Pipeline Review - 2014
5/21/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Genmab A/S’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Gilead Sciences, Inc. - Product Pipeline Review - 2014
5/21/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Gilead Sciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Oxygen Biotherapeutics, Inc. (OXBT) - Financial and Strategic SWOT Analysis Review
5/21/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions
5/20/2014 | published by: Kalorama Information
... notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this ...  |  read more...
USD 4,500
Conference Documentation: ADC Summit 2014
5/19/2014 | published by: SMI Publishing, Ltd
... Group is proud to announce that the ADC Summit 2013 conference will be returning to London in 2014. If you are interested in getting involved, please contact Dale Butler on 020 7827 6044 or via email  |  read more...
USD 788
Agricultural Enzymes Market by Type (Carbohydrase, Lipase, Protease, Polymerase & Nuclease), by Application (Fertility, Growth, & Control Products), by Crop Type, & by Geography - Global Trends & Forecast to 2018
5/19/2014 | published by: MarketsandMarkets
... an important role in maintaining soil health. The enzymatic activity in soil is derived from cell-associated or free enzymes. A balance of chemical, physical, and biological components contributes to maintaining soil health. Healthy soil keeps ...  |  read more...
USD 4,650
Caprion Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... validation of biomarkers using its proteomics discovery platform CellCarta. Caprion’s CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and ...  |  read more...
USD 750
Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... through the treatment decisions. Its product portfolio iincludes nine commercial molecular diagnostic tests, namely, six predictive medicine tests; one prognostic medicine test; and two personalized medicine tests in the areas of oncology and CNS related ...  |  read more...
USD 750
5  6  7  8    10    12  13  14